Steve L. Taylor
Papers
1
Total Citations
9
H-Index
1
About
Dr. Steve L. Taylor is a distinguished researcher in haemostasis and thrombosis, with a specialized focus on the molecular diagnostics of bleeding disorders. His major contributions center on refining laboratory assays for von Willebrand Disease (VWD), particularly the challenging type 2N variant, which mimics mild haemophilia A. In his pivotal 2002 work, Dr. Taylor developed and validated an automated screening assay for VWD type 2N by evaluating the factor VIII (FVIII) binding activity of von Willebrand factor (VWF). This innovation provided a critical, reproducible tool for differentiating type 2N from haemophilia A, directly impacting the diagnostic work-up of affected families. While his most-cited paper has garnered 9 citations, its influence is notable for its targeted clinical utility in specialized coagulation laboratories. Dr. Taylor’s work has helped streamline the identification of mutations at the N-terminal end of the mature VWF subunit, advancing precision in genetic counseling and treatment planning for patients with these rare but significant bleeding phenotypes. His research remains a cornerstone for clinicians navigating complex VWD diagnoses.
Research Focus
Key Achievements
Top Papers
- 1